Intellicell Biosciences, Inc. — Form D
Intellicell Biosciences, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-23. The offering totals $3.5M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-02-23
- Form: D
- Accession: 0001013762-12-000375
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.5M
- Amount sold: $2.0M
- Remaining: $1.5M
- Minimum investment: $5K
- Investors: 13
- Date of first sale: 2012-02-09
- Revenue range: $1 - $1,000,000
- SEC file number: 021-173887
Issuer
- Name: Intellicell Biosciences, Inc.
- CIK: 0001125280
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 460 Park Avenue, 17th Floor, NEW YORK, NY, 10022
- Phone: 646-576-8700
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Myron A Holubiak | Director | NEW YORK, NY |
| Michael A Hershman | Director | NEW YORK, NY |
| Leonard A Mazur | Director | NEW YORK, NY |
| Steven A Victor | Director | NEW YORK, NY |
| Steven A Victor | Executive Officer | NEW YORK, NY |
| Stuart A Goldfarb | Director | NEW YORK, NY |
Other filings by this issuer (5)
More